Liquid biopsy testing that captures treatment-guiding biomarkers from a patient's blood and body fluids.
Consented intake · your records travel with you · nothing moves without your sign-off
Genomic Testing Cooperative's Liquid Trace analyzes blood and other bodily fluids, including urine and saliva, for biomarkers such as DNA, RNA, and proteins. The goal is to gather distinctive markers that can guide treatment and monitor disease progression, with applications that include minimum residual disease monitoring and early detection.
Prefer the source? Genomic Testing Cooperative, Liquid Trace's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Genomic Testing Cooperative, Liquid Trace handles billing.
We don't have confirmed insurance details for Genomic Testing Cooperative, Liquid Trace yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Genomic's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Cancer types served
Other providers in similar categories.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.